Seagen Inc. (SGEN)
After hours:
Chart Events
Performance Outlook
| Previous Close | 179.33 |
| Open | 178.78 |
| Bid | 171.59 x 1200 |
| Ask | 177.51 x 1000 |
| Day's Range | 174.55 - 179.04 |
| 52 Week Range | 105.43 - 192.79 |
| Volume | |
| Avg. Volume | 1,354,301 |
| Market Cap | 32.499B |
| Beta (5Y Monthly) | 0.82 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.84 |
| Earnings Date | Apr 27, 2022 - May 02, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 159.88 |
- Benzinga
SVB Leerink's Pro-forma Analysis Of Speculated Merck/Seagen Deal - What Investors Need To Know
SVB Securities conducted a pro-forma analysis of the financial impact to Merck & Co Inc (NYSE: MRK) from a potential acquisition of Seagen Inc (NASDAQ: SGEN). The analysts refrain from commenting on the probability of the deal happening. The analysis suggests that the short-term impact on EPS from the potential acquisition will likely be meaningfully dilutive. Related: Merck Shows Takeover Interest In Seagen: WSJ. According to SVB, the deal decreases forecasted GAAP EPS by -12%, -7%, and -2% in
- Zacks
Seattle Genetics (SGEN) Moves 12.7% Higher: Will This Strength Last?
Seattle Genetics (SGEN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- Simply Wall St.
Are Investors Undervaluing Seagen Inc. (NASDAQ:SGEN) By 45%?
Does the June share price for Seagen Inc. ( NASDAQ:SGEN ) reflect what it's really worth? Today, we will estimate the...
